Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRCULATE: ctDNA-Based Adjuvant Treatment Decision in Stage II Colon Cancer
NCT04120701Phase 3Recruiting
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Jan 2020
- Primary completion
- Mar 2032
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of fluorouracil, folinic acid, oxaliplatin in colon cancer, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Jan 2020; status: recruiting.
02
Drugs
fluorouracilfolinic acidoxaliplatin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT04120701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04120701.